Laurion Capital Management LP Glaukos Corp Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$37.23 - $50.97 $2 Million - $2.73 Million	-53,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $1.54 Million - $2.51 Million	53,600 New	53,600 $2.06 Million
Q3 2019 Nov 13, 2019	SELL	$58.58 - $83.91 $1.16 Million - $1.67 Million	-19,876 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$63.59 - $78.71 $387,771 - $479,973	-6,098 Reduced 23.48%	19,876 $1.5 Million
Q1 2019 May 08, 2019	BUY	$50.75 - $80.54 $1.32 Million - $2.09 Million	25,974 New	25,974 $2.04 Million
Q1 2018 May 14, 2018	SELL	$26.05 - $34.5 $237,055 - $313,950	-9,100 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$24.5 - $36.01 $222,950 - $327,691	9,100	9,100 $233,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.